This Morning’s Top Headlines – Oct. 14 | Morning News NOW

Subscribe to The Global Herald in Google News

NBC News published this video item, entitled “This Morning’s Top Headlines – Oct. 14 | Morning News NOW” – below is their description.

An FDA panel meets to consider Moderna booster shots, the White House is attempting to ease the supply chain bottleneck and inflation continues to rise.

» Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC

» Watch more NBC video: http://bit.ly/MoreNBCNews

NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.

Connect with NBC News Online!

NBC News App: https://smart.link/5d0cd9df61b80

Breaking News Alerts: https://link.nbcnews.com/join/5cj/breaking-news-signup?cid=sm_npd_nn_yt_bn-clip_190621

Visit NBCNews.Com: http://nbcnews.to/ReadNBC

Find NBC News on Facebook: http://nbcnews.to/LikeNBC

Follow NBC News on Twitter: http://nbcnews.to/FollowNBC

#News #MorningNews #TopNews

NBC News YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.


Subscribe to The Global Herald in Google News

About This Source - NBC News

NBC News is the news division of the American broadcast television network NBC.

NBC News aired the first, regularly scheduled news program in American broadcast television history on February 21, 1940.

Recent from NBC News:

  • Full Interview: Santa Fe DA Speaks On Alec Baldwin Fatal Shooting
  • Playing In Pain: Braves Pitcher Threw 16 Pitches On Fractured Fibula
  • Top Story with Tom Llamas – Oct. 27 | NBC News Now
  • In This Story: Moderna

    Moderna is an American biotechnology company based in Cambridge, Massachusetts that focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.

    CEO: Stéphane Bancel (2011–)

    Stock ticker: (NASDAQ:MRNA)

    5 Recent Items: Moderna

  • Moderna will be the first trillion dollar health-care company, says Stephen Weiss
  • This Morning’s Top Headlines – October 26 | Morning News NOW
  • FDA Advisory Board Expected To Discuss Pfizer’s Covid Vaccine For Kids
  • Moderna says low dose of vaccine safe, effective in children 6 to 11
  • CDC approves Moderna and J&J Covid-19 vaccine boosters
  • Leave a Comment

    We don't require your email address now, just your name. BUT, if you do add it, you may be notified if there are replies to your comment. Please make respectful comments, which add value, and avoid personal attacks on others. Comments failing to adhere to these guidelines will not be published.

    Posting....